Mileage Communications organised the first virtual media briefing for Elixir Medical Corporation, with 3 distinguished cardiologists being involved in the event. The objective of the exercise was to present the results of a 24-month clinical study for the DynamX™ Coronary Bioadaptor System, and successful implantation of the bioadaptor on a heart patient.
The bioadaptor opens and supports the coronary artery during healing, while accommodating the vessel’s ability to grow in response to disease progression. The briefing illuminated the bioadaptor’s unique advantages over current drug-eluting stents, as well as its successes in the testing process.
Dr. Antonio Colombo, MD, co-principal investigator of the study, Professor of Cardiology at Humanitas Medical School, Senior Consultant in Interventional Cardiology at Humanitas Research Hospital, Rossano, Milan, and Director of the Cardiac Catheterisation Laboratory in Columbus Hospital, Milan, Italy said: “At 24 months, the bioadaptor continued to show no thrombosis and no target vessel revascularisation, which demonstrates a strong safety profile and excellent performance.”
Prof. Jack Tan, Deputy Head and Senior Consultant, Department of Cardiology, National Heart Centre of Singapore and also Head of Cardiology, Sengkang General Hospital, said: “Drug-eluting stents (DES) are the current gold standard treatment, but there is an opportunity to improve upon that technology. The promise of the Bioadaptor is in addressing the 2-3% adverse event rate that occurs with DES each year, which may improve long-term patient outcomes.”
Prof. Lim Soo Teik, Deputy Medical Director and Senior Consultant, Department of Cardiology, and Director of the Cardiac Catheterisation Laboratory, National Heart Centre Singapore, said: “DynamX Bioadaptor has demonstrated excellent clinical results, and performed well in the procedure demonstrated at the Singapore LIVE conference.”
The virtual media briefing was a resounding success, with participants from the U.S., Australia, Malaysia, Italy and Singapore attending the presentation.